Charlotte Bernigaud

Université Paris Est
Creteil, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Oral Ivermectin and 5% Permethrin Cream for Severe Scabies. Reply.

Oral Ivermectin and 5% Permethrin Cream for Severe Scabies. Reply.

Journal: The New England journal of medicine

Published: August 19, 2026

Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies.

Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies.

Journal: The New England journal of medicine

Published: May 06, 2026

Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial.

Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial.

Journal: BMJ (Clinical research ed.)

Published: January 06, 2026

A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b Study.

A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b Study.

Journal: Dermatology and therapy

Published: September 27, 2025

Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical study.

Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical study.

Journal: Immunotherapy

Published: September 01, 2025

Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis.

Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis.

Journal: CPT: pharmacometrics & systems pharmacology

Published: April 24, 2025

Scabies.

Scabies.

Journal: Nature reviews. Disease primers

Published: August 22, 2024

Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis.

Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis.

Journal: The Journal of allergy and clinical immunology

Published: July 26, 2024

Mycobacterium chelonae cutaneous infections unrelated to invasive procedures: A multicentre retrospective case series.

Mycobacterium chelonae cutaneous infections unrelated to invasive procedures: A multicentre retrospective case series.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: February 01, 2024

Real-life practice of reflectance confocal microscopy in France: A prospective multicenter study.

Real-life practice of reflectance confocal microscopy in France: A prospective multicenter study.

Journal: Journal of the American Academy of Dermatology

Published: July 27, 2023

Worldwide differences in clinical management practices of scabies: A survey using clinical vignettes.

Worldwide differences in clinical management practices of scabies: A survey using clinical vignettes.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: March 12, 2023

Severe Scabies: A French Multi-centre Study Involving 95 Patients with Crusted and Profuse Disease and Review of the Literature.

Severe Scabies: A French Multi-centre Study Involving 95 Patients with Crusted and Profuse Disease and Review of the Literature.

Journal: Acta dermato-venereologica

Published: November 21, 2022

Showing 1-12 of 62

Last Updated: 09/26/2026